Senti Biosciences Inc (SNTI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.38M
Last updated: Nov 17, 2026 at 11:06 AM ET
Senti Biosciences Inc (SNTI) Competitors
The companies most similar to Senti Biosciences are Neurosense Therapeutics (NRSN), Ensysce Biosciences (ENSC) and Soligenix (SNGX). By market cap, Senti Biosciences ranks 8th of the 13 companies on this page; Quantum BioPharma (QNTM) is the largest at $10.35M.
Peer Comparison
SNTI's ROIC of 1039.8% is above the peer median of -205.3%, and its revenue growth of -100.0% is below the median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Senti Biosciences (SNTI) | $5.38M | N/A | 57.2x | 0.0% | 1039.8% | -100.0% | 0.00% |
| Neurosense Therapeutics Ltd (NRSN) | $3.21M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Ensysce Biosciences Inc (ENSC) | $8.14M | N/A | 1.2x | -280.5% | -260.6% | -15.1% | 0.00% |
| Soligenix Inc. (SNGX) | $7.50M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Quantum BioPharma Ltd. (QNTM) | $10.35M | N/A | N/A | 0.0% | -150.1% | 0.0% | 0.00% |
| CNS Pharmaceuticals Inc (CNSP) | $4.22M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tempest Therapeutics Inc (TPST) | $7.64M | N/A | N/A | 0.0% | -783.6% | 0.0% | 0.00% |
| Exicure Inc (XCUR) | $7.07M | N/A | N/A | 0.0% | N/A | 928.0% | 0.00% |
| GT Biopharma Inc (GTBP) | $7.67M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| FibroBiologics, Inc. Common Stock (FBLG) | $6.57M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Imunon Inc (IMNN) | $4.08M | N/A | N/A | 0.0% | -131.5% | 0.0% | 0.00% |
| GRI Bio Inc. (GRI) | $3.72M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Xenetic Biosciences Inc (XBIO) | $3.89M | N/A | 1.2x | -75.9% | N/A | 12.0% | 0.00% |
| Peer median | $6.82M | N/A | 1.2x | 0.0% | -205.3% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Senti Biosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Neurosense Therapeutics Ltd (NRSN) | Neurosense Therapeutics Ltd (NRSN) is a clinical-stage biotechnology firm dedicated to innovating treatments for neurodegenerative diseases... | |
| Ensysce Biosciences Inc (ENSC) | Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs. | ENSC competitors |
| Soligenix Inc. (SNGX) | Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States. | SNGX competitors |
| Quantum BioPharma Ltd. (QNTM) | Quantum BioPharma Ltd. (QNTM) is an innovative biotechnology company focused on advancing transformative therapies for oncology and autoimmune diseases. | QNTM competitors |
| CNS Pharmaceuticals Inc (CNSP) | CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central... | CNSP competitors |
| Tempest Therapeutics Inc (TPST) | Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated... | TPST competitors |
| Exicure Inc (XCUR) | Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases... | XCUR competitors |
| GT Biopharma Inc (GTBP) | GT Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its... | GTBP competitors |
| FibroBiologics, Inc. Common Stock (FBLG) | FibroBiologics, Inc. is an innovative biotechnology company dedicated to advancing regenerative medicine through its proprietary fibroblast cell technology... | FBLG competitors |
| Imunon Inc (IMNN) | Imunon Inc. is a clinical-stage biotechnology company at the forefront of developing innovative immune-mediated therapies targeting cancer and infectious... | IMNN competitors |
| GRI Bio Inc. (GRI) | GRI Bio Inc. is an innovative biotechnology company focused on leveraging microbiome technology to develop cutting-edge therapeutics in immunology and oncology. | GRI competitors |
| Xenetic Biosciences Inc (XBIO) | Xenetic Biosciences, Inc., a biopharmaceutical company, is focused on advancing XCART... | XBIO competitors |
Frequently Asked Questions About SNTI
Who are Senti Biosciences' main competitors?
The companies most similar to Senti Biosciences include Neurosense Therapeutics (NRSN), Ensysce Biosciences (ENSC), Soligenix (SNGX), Quantum BioPharma (QNTM) and CNS Pharmaceuticals (CNSP), listed from the closest match.
Who is Senti Biosciences' biggest competitor?
Quantum BioPharma (QNTM) is the largest of the similar companies at $10.35M; Neurosense Therapeutics (NRSN) is the closest match by business profile, size, sector and industry.
How does SNTI stock compare with its competitors?
SNTI's P/S is 57.2x against a peer median of 1.2x; its net margin is 0.0% against a peer median of 0.0%.
Which of Senti Biosciences' competitors pays a higher dividend?
Senti Biosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Senti Biosciences bigger than its competitors?
No. Senti Biosciences is 8th by market cap among the 13 companies on this page; the largest is Quantum BioPharma (QNTM) at $10.35M.
SNTI pages: Overview, Earnings, Forecast, Financials, Competitors